Division of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Emergency Department, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Diabet Med. 2017 Jul;34(7):973-982. doi: 10.1111/dme.13325. Epub 2017 Feb 28.
The clinical relevance of hyperglycaemia in an emergency department population remains incompletely understood. We investigated the association between admission blood glucose levels and adverse clinical outcomes in a large emergency department cohort.
We prospectively enrolled 7132 adult medical patients seeking emergency department care in three tertiary care hospitals in Switzerland, France and the USA. We used adjusted multivariable logistic regression models to examine the association between admission blood glucose levels and 30-day mortality, as well as adverse clinical course stratified by pre-existing diabetes and principal medical diagnoses.
In 6044 people without diabetes (84.7%), severe hyperglycaemia, defined as a glucose level of > 11.1 mmol/l (200 mg/dl), was associated with a doubling in the risk of 30-day mortality [adjusted odds ratio (OR) 1.9; 95% confidence interval (95% CI), 1.1 to 3.3; P = 0.018] and a three-fold increase in the risk of intensive care unit admission (adjusted OR 3.0; 95% CI, 1.9 to 4.9; P < 0.001). These associations were similar among different diagnoses. In the population with diabetes (n = 1088), no association with 30-day mortality was found (adjusted OR 1.0; 95% CI, 0.6 to 1.8; P for interaction = 0.001), whereas the association with intensive care unit admission was weaker (adjusted OR 2.4; 95% CI, 1.5 to 4.1; P for interaction = 0.011). Overall 30-day mortality was higher in those with diabetes than in those without (6.1 vs. 4.4%, P = 0.015).
In this large medical emergency department patient cohort, admission hyperglycaemia was strongly associated with adverse clinical course in people without diabetes. (Clinical Trial Registry No: NCT01768494).
在急诊科人群中,高血糖的临床相关性仍不完全清楚。我们调查了在瑞士、法国和美国的三家三级保健医院的大型急诊科队列中,入院血糖水平与不良临床结局之间的关系。
我们前瞻性地纳入了 7132 名在瑞士、法国和美国的三家三级保健医院就诊的成年内科患者。我们使用调整后的多变量逻辑回归模型,检查入院血糖水平与 30 天死亡率之间的关系,以及按预先存在的糖尿病和主要医疗诊断分层的不良临床病程。
在 6044 名无糖尿病(84.7%)的患者中,严重高血糖定义为血糖水平>11.1mmol/l(200mg/dl),与 30 天死亡率增加两倍相关(调整后的优势比[OR]1.9;95%置信区间[95%CI],1.1 至 3.3;P=0.018),与重症监护病房(ICU)入院的风险增加三倍相关(调整后的 OR 3.0;95%CI,1.9 至 4.9;P<0.001)。这些关联在不同的诊断中是相似的。在有糖尿病的患者中(n=1088),与 30 天死亡率无关联(调整后的 OR 1.0;95%CI,0.6 至 1.8;P 交互=0.001),而与 ICU 入院的关联较弱(调整后的 OR 2.4;95%CI,1.5 至 4.1;P 交互=0.011)。总体而言,有糖尿病的患者 30 天死亡率高于无糖尿病的患者(6.1%比 4.4%,P=0.015)。
在这个大型内科急诊科患者队列中,入院高血糖与无糖尿病患者的不良临床病程密切相关。(临床试验注册号:NCT01768494)